I have a flow system

Chapter 188 It took 250
Zhao Deqing, the former chairman of the company, is of course aware of the major changes in the company.

Immediately contacted the broker again, hoping to chat with Wu Zhou again, at least add some points.

"Mr. Wu said that the market value should be calculated according to the market value. In fact, Mr. Zhao, my suggestion is that you can keep the stock. After all, Mr. Wu also said that the stock will be sold at least ten years from now. , all the profits will be invested in the company's research and development, you think, with Mr. Wu who puts so much emphasis on research and development, the stocks in your hands will definitely make a lot of money in the future, and at least double the number in ten years."

When Zhao Deqing heard this, he just rolled his eyes. Isn't it because of Wu Zhou's decision that he is so eager to sell now.

Although the medical industry focuses on research and development, breakthroughs are possible.

But it does not mean that heavy research and development will definitely lead to breakthroughs.

Moreover, even if all the profits of the entire company are added in, it will be in the hundreds of millions a year, and medical equipment is the head of a domestic enterprise, and the research and development costs for so many years start at billions. The funds can be exerted dozens of times.

In his opinion, Wu Zhou's strategy of focusing on research and development is good. Even an outsider has to say that it is really courageous, but that's all. He doesn't have much hope for the future of the company.

In addition, as a former chairman whose position has been wiped out, holding so many shares, he has neither post salary nor dividends, and has not paid dividends for ten years.

Such a large asset has been cashed out directly, so it is not good to use it anywhere.

And these shares are most of his net worth, and some time ago, pulling out a group of people from the original company to start a new one, all of which cost money.

So after considering it comprehensively, he decided to sell it immediately.

"Mr. Liu, Ming people don't talk dark words. Please help me talk to Mr. Wu about this matter. After the matter is completed, the extra part will be added to five." Zhao Deqing finally said through gritted teeth.

After the broker heard Zhao Deqing's words, his breathing became stagnant.

Zhao Deqing could hear the person on the phone, and then took a deep breath.

"Mr. Zhao, I'm busy. I really want to help, but I really can't. You can calculate it yourself. That's the price. It seems that Mr. Wu will go back tomorrow. He is very busy, so it may not be the case next time." When is it?" Just kidding, if it is the first time to cooperate with Wu Zhou, there is a high probability that the broker will really agree with Zhao Deqing's plan.

After all, who can refuse such a large sum of money.

But the experience of cooperating with Wu Zhou many times told him that Wu Zhou has a very powerful intelligence network.

Back then, Wu Zhou gave him a list of the first medical device company, the psychological bottom line price of each shareholder, before they started talking.

At the beginning, he thought that those bottom line prices were just a joke, but in the subsequent negotiation process, he found out.

Almost without exception, the final transaction is at the bottom line price.

And the bottom line price of Zhao Deqing given by Mr. Wu is the original price.

Therefore, as a role of just a mouthpiece, there is no room for him to make a difference.

"Okay, that's the price."

After a long silence, Zhao Deqing finally compromised without any surprise.

After all, Wu Zhou has obtained the vast majority of the company's shares. As a top rich man worth hundreds of billions, he has means, or a team that can help him empty out the company he acquired.

If he really wants to fight against Wu Zhou, there is a high probability that he will end up with nothing.

It's better to have peace of mind, with such a large sum of money, it is enough.

"Mr. Zhao, I have to confirm with you again. You won't change your mind when you arrive at the scene."

Of the three medical device companies, Zhao Deqing and Mi Xuexia's medical device company was the most troublesome to acquire, but the acquisition amount was also the lowest. In the end, it only cost 35 billion.

Originally, a 50% premium was negotiated, but in the end, due to the couple's various struggles, the overall actual premium was only 25%.

This tandem saved Wu Zhou 7 million.

The three medical device companies in his hands cost Wu Zhou a total of 153 billion.

In addition to the 70 billion from Kexing, there are also signing fees for some talents, and the top researchers who have already arrived in March have received project funds.

In terms of biomedicine, it has spent nearly [-] billion now.

Adding these together, the numbers are still encouraging, almost 250 billion.

In January and February, in this special market situation, the total sales revenue and profit of Wu Zhou's company was about 1.2 billion.

For additional income, about 2000 mask production lines have been booked, with a payment of 36 billion and a profit estimate of about 30 billion.

So add it up.
In the first two months, Wu Zhou's total profit was about 313 billion.

It cost 250 billion at once, but if you look at the company's financial report, there is still a profit of 63 billion on the account.

It was also because there was enough money, and Wu Zhou spent it lavishly enough.

All the revenue and profits of the medical device company in the following ten years will be spent on the research and development of the company's industrial chain.

This is not a joke, of course it is to be the best.

Throughout the first ten days of March, Wu Zhou devoted almost all of his time to these medical-related enterprises in his hands.

After all, it cost so much money.

The few medical device companies he bought were all the result of Wu Zhou's careful selection.

Not just the potential of its own R&D team.

There is also the production capacity and technical capacity of the company's holding OEM factories.

There is the best OEM factory in the domestic industry, and the production quality is top-notch even in the world.

In addition, there are few domestic manufacturers with core technologies and leading technologies, and some core component technologies of medical devices can be directly produced. Although the performance is slightly inferior to the national first-line level, it is not far behind.

Now that we have the best OEM quality control factory in hand, of course, the related products of the three medical devices can be transferred as soon as possible.

But some things factories may not be able to produce.

At this time, some engineers have made targeted design and debugging, and the production level of other holding companies is average. If the rectification should be rectified, and the production should be stopped, the standard of the produced products must be improved.

In terms of industrial chain production optimization, we will also cooperate with Wu Zhou's original technical department to strive for further improvement in quality control and automated production.

As for the core component technology, since it is not as good as the international first-tier at the moment, we should increase research and development, and strive to reach the international first-tier, or even surpass their level. At the same time, Wu Zhou will also screen the necessary patents to see if it can buy it.

Look again, whether the top experts behind these technologies can be poached away.

Scientific research requires time, money, people, and direction.After all, the direction is wrong, and everything is useless.

It just so happened that Wu Zhou could satisfy all these things, except for the lack of time.

After spinning for many days, Wu Zhou also felt a little tired in his brain.

But suddenly Wu Zhou saw a piece of news.

"On March 3, the New York stock market plummeted at the opening, triggering the circuit breaker mechanism, and the composite index fell by more than 9%."

Wu Zhou "."

(End of this chapter)